These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 11293903
1. Realistic pathologic classification of acute myeloid leukemias. Arber DA. Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903 [Abstract] [Full Text] [Related]
2. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Arber DA, Stein AS, Carter NH, Ikle D, Forman SJ, Slovak ML. Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285 [Abstract] [Full Text] [Related]
3. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification]. Leymarie V, Galoisy AC, Falkenrodt A, Lessard M. Ann Biol Clin (Paris); 2004 May; 62(5):513-20. PubMed ID: 15355801 [Abstract] [Full Text] [Related]
4. Diagnosis and classification of the acute leukemias: recent advances and controversial issues. Taylor CG, Stasi R, Bastianelli C, Venditti A, Del Poeta G, Amadori S, Sargent J. Hematopathol Mol Hematol; 1996 May; 10(1-2):1-38. PubMed ID: 8792146 [Abstract] [Full Text] [Related]
5. Role of FAB classification of acute leukemias in era of immunophenotyping. Sachdeva MU, Ahluwalia J, Das R, Varma N, Garewal G. Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842 [Abstract] [Full Text] [Related]
6. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia]. Braham-Jmili N, Sendi-Senana H, Labiadh S, Ben Abdelali R, Ben Abdelaziz A, Khelif A, Saad A, Kortas M. Ann Biol Clin (Paris); 2006 Oct; 64(5):457-65. PubMed ID: 17040877 [Abstract] [Full Text] [Related]
7. Acute myeloid leukemia. Heerema-McKenney A, Arber DA. Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162 [Abstract] [Full Text] [Related]
8. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Terstappen LW, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B. Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298 [Abstract] [Full Text] [Related]
9. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C. Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458 [Abstract] [Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A. Pathobiology; 2007 May; 74(2):97-114. PubMed ID: 17587881 [Abstract] [Full Text] [Related]
13. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Kozlov I, Beason K, Yu C, Hughson M. Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957 [Abstract] [Full Text] [Related]
18. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Fagioli F, Cuneo A, Piva N, Carli MG, Previati R, Balboni M, Tomasi P, Cariani D, Scapoli G, Castoldi G. Cancer; 1992 Jul 01; 70(1):77-85. PubMed ID: 1606550 [Abstract] [Full Text] [Related]
19. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P. Am J Clin Pathol; 2003 May 01; 119(5):663-71. PubMed ID: 12760284 [Abstract] [Full Text] [Related]